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Prevention of Ischemia/Reperfusion Injury in the Rat Liver by 
Atrial Natriuretic Peptide 
MANFRED BILZER, ROCHUS WITTHAUT, GUSTAV PAUMGARTNER, and ALEXANDER L. GERBES 
Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany 
Background/Aims: Atrial natriuretic peptide (ANP) pro­
tects against hypoxia/reoxygenation-induced damage 
of cultured hepatocytes, thus suggesting a therapeutic 
potential in the liver. Therefore, the effects of ANP on 
hepatic ischemia/reperfusion injury after warm isch­
emia were studied. Methods: Livers of male Sprague-
Dawley rats subjected to 60 minutes of warm ischemia 
at 37°C were perfused in the presence or absence of 
200 and 20 nmol/L ANP. Results: Sinusoidal lactate 
dehydrogenase efflux increased to 2000 ± 264 and 
126 ± 50 mU min 1 g liver 1 after 1 minute and 
60 minutes of reperfusion, but it only increased to 
1240 ± 160 and 22 ± 16 mU min 1 g liver 1 in the 
presence of 200 nmol/L ANP during the preischemic 
and postischemic perfusion period. The postischemic 
bile flow (0.67 ± 0.18 μΐ min"1 g liver1) was signifi­
cantly improved with 200 nmol/L ANP (0.92 ± 0.05) 
and showed a linear correlation to biliary glutathione 
excretion. In contrast, 20 nmol/L ANP had no protec­
tive effects. Administration of 200 nmol/L ANP during 
the preischemic perfusion period alone (but not after 
starting reperfusion) markedly preserved postischemic 
liver function. Conclusions: Continuous ANP adminis­
tration or ANP pretreatment alone prevents hepatic 
ischemia/reperfusion injury, possibly because of influ­
ences on intracellular signal transduction processes. 
The correlation between bile flow and biliary glutathi­
one excretion supports the hypothesis that biliary gluta­
thione transport is one of the osmotic driving forces in 
postischemic bile formation. 
Ischemia/reperfusion-induced in jury o f the l iver is a major c l in ica l p rob l em after l iver t ransplantat ion, par­
t ial hepatectomy, and shock. The mechanisms o f isch­
emic l iver in ju ry are not yet fu l l y understood. Dep l e t i on 
of adenosine tr iphosphate, disturbance o f intrace l lu lar 
calcium homeostasis, and act ivat ion o f phospholipase A 2 
are proposed as major pathophysio logical processes dur ­
ing ischemia leading to cell i n ju ry , b u t the sequence o f 
these events remains con t rove r s i a l . 1 - 4 The reperfusion o f 
ischemic organs may lead to the aggravation o f ischemic 
in jury , w h i c h is generally referred to as reperfusion i n ­
jury . 5 In f lammatory products o f activated Kupffer 's cells 
and recruited granulocytes, such as reactive oxygen spe­
cies, could cont r ibute to hepatic reperfusion i n j u r y . 6 - 1 1 
The incomplete understanding o f the ischemia/reperfu­
sion in jury may explain the lack o f established pharmaco­
logical intervent ions prevent ing ischemic liver damage. 
Recent studies suggest a therapeutic potent ia l o f the 
atr ia l nat r iure t i c pept ide ( AN P ) , a c i rculat ing hormone 
released ma in l y by the atr ia o f mammal ian hearts i n 
response to vo lume expansion or cardiac hypoxia. 1 2 ' 1 ^ 
A N P , infused upon reperfusion, preserves kidney func­
t i on after renal i s c h e m i a . 1 1 1 5 As a possible mechanism, 
the antagonism o f catecholamine-mediated renal vaso­
constr ic t ion resul t ing i n an increase of glomerular filtra­
t i on rate and tubu lar flow and the prevention o f i n t r a t u -
bular obst ruct ion by pro te in casts have been discussed. 
Furthermore , A N P protects cu l tured hepatocytes against 
damage induced by hypoxia/reoxygenation or oxidative 
stress. 1 6 ' 1 7 I t has been proposed that A N P exerts this 
cytoprotect ive effect by a cyclic guanosine monophos­
phate (cGMP)-mediated decrease o f intracellular cal-
16 
c i u m . 
So far, the effect o f A N P on the intact or ischemic 
l iver has not been investigated. Therefore, we studied 
the effects o f A N P on the ischemia/reperfusion damage 
after 60 minutes o f w a r m ischemia using the isolated 
perfused rat l iver. The sinusoidal release o f lactate dehy­
drogenase ( L D H ) , bi le flow, and the carrier-mediated 
excretion o f g lu ta th ione i n t o b i l e 1 8 - 2 1 were determined 
as parameters o f cell damage and postischemic liver func­
t i o n . 
Materials and Methods 
Perfusion of Rat Liver 
Male Sprague—Dawley rats weighing 250—300 g were 
purchased from SAVO (Kisslegg, Germany) and housed in a 
climatized room w i th a 12-hour light-dark cycle. The animals 
had free access to chow (Standard-Diet, Al tromin 1314 Lage, 
Germany) and water up to the time of the experiments. After 
anesthetizing the animals w i th pentobarbital (50 mg/kg body 
wt , intraperitoneally), the livers were perfused in situ w i th 
Abbreviations used in this paper: ANP, atrial natriuretic peptide; 
DTNB, 5,5'-dithiobis(nitrobenzoic acid); GSH, reduced glutathione; 
GSSG, glutathione disulfide; LDH, lactate dehydrogenase; NADPH, 
nicotinamide adenine dinucleotide phosphate. 
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Figure 1. Experimental protocol. For detailed explanation, see Materi­
als and Methods. 
hemoglobin-free and albumin-free, bicarbonate-buffered Krebs'-
Henseleit solution (pH 7.4, 37°C) gassed wi th 95% 0 2 and 
5% C 0 2 . 2 2 The perfusion medium was pumped through the 
livers with a membrane pump at a constant flow rate of 3 0 -
3.5 m L m i n - 1 - g l i v e r - 1 in a nonrecirculating fashion. The 
bile duct was cannulated wi th polyethylene PE 10 cubing, 
and bile was collected in preweighed tubes containing 4% 
sulfosalicylic acid to prevent autoxidation of reduced glutathi­
one (GSH). After cannulation of the portal vein, the livers 
were perfused for 30 minutes. Thereafter, the perfusion flow 
was lui'iicd υίΤ ibr ου minutes to produce warm ischemia 
(37°C). Then, the perfusion was continued for another 60 mi ­
nutes. Portal perfusion pressure was monitored continuously 
during the total perfusion time (90 minutes). The study was 
registered with the local animal welfare committee. 
Experimental Design 
Two groups of rats were studied wi th continuous liver 
perfusion without ischemia, and five groups were subjected to 
ischemia/reperfusion. Group 1 underwent continuous perfu­
sion as follows: (1) controls, continuous perfusion for 90 min­
utes (n = 6); and (2) 200 nmol/L ANP, continuous perfusion 
for 90 minutes with administration of dose between 40 and 
70 minutes of perfusion (n = 4). Group 2 was subjected to 
ischemia/reperfusion as follows (Figure 1): (1) untreated, 30 
minutes of perfusion, 60 minutes of ischemia, and reperfusion 
for 60 minutes (n = 5); (2) 20 nmol/L ANP, 20 nmol/L ANP 
during 20 minutes unt i l ischemia, 60 minutes of ischemia, 
and reperfusion for 60 minutes with 20 nmol/L ANP (n = 4); 
(3) 200 nmol/L ANP, 200 nmol/L ANP during 20 minutes 
unt i l ischemia, 60 minutes of ischemia, and reperfusion for 60 
minutes wi th 200 nmol/L ANP (n = 4); (4) 200 nmol/L ANP 
before ischemia, 200 nmol/L ANP during 20 minutes unt i l isch­
emia, 60 minutes of ischemia, and reperfusion for 60 minutes 
without ANP (n = 4); and (5) 200 nmol/L ANP after ischemia. 
30 minutes of perfusion, 60 minutes of ischemia, and reperfu­
sion wi th 200 nmol/L ANP for 20 minutes after reperfusion 
(n = 4). 
Rat ANP (Novabiochem, Läufelfingen, Switzerland) was 
dissolved in perfusion buffer and infused into the portal inflow 
of the perfusion system. 
Analytical Methods 
Glutathione disulfide (GSSG) in bile was measured by 
its reaction with nicotinamide adenine dinucleotide phosphate 
(NADPH) catalyzed by GSSG reductase at 340-400 nm in 
a dual-wavelength spectrophotometer.23 The concentration of 
GSH in bile and perfusate was measured together wi th GSSG 
in a kinetic assay using NADPH, GSSG reductase, and 5,5-
dithiobis(nitrobenzoic acid) (DTNB). 2 1 GSH values were ob-
tained by the difference between total glutathione (GSH + 
GSSG) and GSSG. The release of thiols into perfusate was 
determined by the reaction with DTNB at 412 nm. 2 5 Thiol 
concentrations were calculated assuming an extinction coeffi-
cient of Ε = 13.6 m m o l ' L " 1 - c m - 1 . 2 6 
Glucose, lactate, pyruvate, and the activity of L D H released 
into the perfusate were analyzed according to standard tests.2 
Statistics 
A l l data are expressed as the mean ± SD. Statistical 
analysis of data was performed using analysis of variance. 
Results 
ANP Administration and Continuous 
Nonischemic Liver Perfusion 
D u r i n g the perfusion period o f 90 minutes, bile 
flow and the bi l iary excretion of G S H and GSSG declined 
Table 1. Continuous Liver Perfusion in the Presence and 
Absence of 200 nmol/L ANP 
200 nmol/L 
Minutes Control ANP 
Portal pressure 30 4.6 1.0 5.5 -+- 1.3 
(cm H20) 60 4.2 - t - 0.7 5.7 H- 1.3 
90 3.8 ± 0.6 5.2 ± 1.8 
LDH efflux 30 4.6 1.8 6.8 ± 3.7 
{rnUrnin"1-^1) 60 4.2 •+- 1.2 6.4 2.9 
90 10.4 5.4 10.7 + 4.0 
Glucose efflux 30 0.90 + 0.15 1.0 -+- 0.24 
(μπιοΙ- min'1-^1) 60 0.61 - t - 0.23 0.60 -4- 0.03 
90 0.58 • j - 0.29 0.49 0.16 
Lactate efflux 30 0.77 + 0.19 0.57 + 0.24 
{μηιοΙηΊίη1^1) 60 0.74 •+- 0.29 0.41 0.13 
90 0.63 ·+· 0.27 0.36 0.12 
Lactate-pyruvate ratio 30 5.2 •+• 2.9 6.8 3.5 
60 7.5 3.2 6.4 ± 4.5 
90 6.4 2.6 5.4 1.1 
Bile flow 30 1.31 ± 0.05 1.22 0.21 
{μΙ· min"1^1) 60 1.07 • j - 0.1 1.09 ± 0.1 
90 0.94 0.14 0.97 0.11 
Biliary GSSG release 30 0.70 0.24 0.74 ± 0.19 
{nmol-min'1-^'1) 60 0.61 0.13 0.60 0.19 
90 0.52 0.17 0.57 0.21 
Biliary GSH release 30 2.44 + 0.80 2.19 - t - 1.06 
{nmol-min^g1) 60 1.73 0.97 1.43 0.74 
90 1.03 •+• 0.60 0.97 ± 0.29 
NOTE. Livers were continuously perfused with oxygenated Krebs-
Henseleit buffer for 90 minutes (control, η = 6) and compared with 
livers exposed to 200 nmol/L ANP from 40 to 70 minutes of perfusion 
time (n = 4). Biliary and sinusoidal efflux rates are calculated from 
biliary and sinusoidal concentrations multiplied by the rate of bile flow 
and perfusate flow per minutes and grams liver weight. Data are given 
as mean ± SD. There was no significant difference between ANP-
treated livers and controls. 
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Table 2. Sinusoidal Efflux Rates of LDH, Thiols, GSH, Glucose, and Lactate During Reperfusion 
1 min of reperfusion 60 min of reperfusion 
Untreated 200 nmol/L ANP Untreated 200 nmol/L ANP 
LDH {mUmin^g *) 2000 ± 264 1240 ± 160 a 126 50 22 ± 16 a 
Thiol {nmol-minrlg" 1) 226 ± 44 137 ± 33 ö 25.0 3.5 19.1 ± 1.3* 
GSH {nmolmin 1-g'1) 91 ± 22 64 ± 12 ö 14.7 •+• 1.8 12.7 ± 2.3 
Lact ate (//mo/ • m/'n"1 • g~1) 12.3 ± 1.3 12.8 ± 1.4 0.20 0.15 0.42 ± 0.19 
Lactate-pyruvate ratio ND ND 9.1 + 3.7 8.1 ± 5.2 
NOTE. Livers were perfused for 30 minutes and then subjected to 60 minutes of warm ischemia. Sinusoidal efflux rates of untreated livers 
(n = 5) after 1 minute and 60 minutes of reperfusion are compared with livers exposed to 200 nmol/L ANP (n = 4) during the preischemic 
and postischemic perfusion period. Data are expressed as mean ± SD. 
ND, not determined. 
aP < 0.01 (treated vs. untreated group). 
bP < 0.05 (treated vs. untreated group). 
slowly (Table 1), wh ich is comparable w i t h previous re-
s u l t s . 2 8 , 2 9 T h i r t y minutes after cannulating the portal 
ve in, the bi l iary excretion of total g lutathione (sum of 
G S H and GSSG) was 3-92 ± 1.26 nmol · m i n - 1 -g l i v e r - 1 
(expressed in G S H equivalents) and decreased to 2.07 ± 
0.92 nmol* m i n ~ l * g l i ve r " 1 at 90 minutes, correspond-
ing to 5 2 % ± 7 % of the value at 30 minutes. Portal 
pressure remained nearly constant dur ing the perfusion 
per iod. L D H release into the perfusate increased s l ight ly , 
ind icat ing negl igible cell damage u n t i l the end o f perfu-
sion. Sinusoidal glucose and lactate efflux rates decreased 
continuously u n t i l the end of perfusion. W h e n 200 nmol/ 
L A N P was infused over 30 minutes, neither porta l pres-
sure nor bi le flow nor bil iary excretion of G S H and GSSG 
were affected. Thus, the excretion of total g lutathione 
(1.95 ± 0.74 nmo l · m i n - 1 - g l i v e r - 1 ; 6 0 % ± 1 1 % ) was 
s imi lar to that o f untreated controls at the end o f perfu-
sion. Equally, 200 nmol/L A N P d id not influence the 
lactate-pyruvate ratio or the sinusoidal efflux rates o f 
glucose, lactate, and L D H . Thus, bile ac id- independent 
bi le flow, bi l iary glutathione transport, and hepatic g l u -
cose product ion are not modulated by 200 nmol/L A N P . 
Continuous Administration of ANP and 
Ischemia/Reperfusion Damage of the 
Liver 
W h e n livers were reperfused after 60 minutes o f 
warm ischemia, L D H release markedly increased i n the 
first minute of reflow to 2000 ± 264 m U * m i n - 1 - g 
l i v e r - 1 (Table 2) and decreased rapidly d u r i n g the fol low-
ing 10 minutes o f reperfusion, but d i d not re turn to 
basal values (Figure 2). L D H release again increased rap-
id ly w i t h i n 30 minutes of reperfusion, reflecting consid-
erable cell damage. Admin is t ra t ion o f 200 nmol/L A N P 
dur ing the preischemic and postischemic perfusion pe-
r iod resulted i n a d i m i n u t i o n of the peak L D H efflux 
(1240 ± 1 1 6 m U - m i n - 1 -g l i v e r - 1 ) 1 minute after start-
ing reperfusion (Table 2). The L D H release then de-
creased to 7 — 14 m U - m i n - 1 *g l i v e r - 1 , wh ich was com-
parable w i t h L D H efflux rates o f livers continuously 
perfused w i t h o u t ischemia for the same durat ion (Table 
1). I n contrast, the t ime course o f postischemic L D H 
release was uninfluenced i n the presence o f 20 nmol/L 
A N P . 
In good agreement w i t h previous results, 2 8 the sinusoi-
dal efflux rates o f thiols, G S H , and lactate were markedly 
increased dur ing the in i t i a l washout phase (Table 2), 
reflecting accumulation of these metabolites i n the extra-
cellular space dur ing ischemia. I n ANP-treated livers, 
the efflux o f thiols and G S H was signif icantly reduced 
(similar to L D H release), ind icat ing that leakiness of cell 
membranes as a consequence of ischemic damage may 
be part ia l ly e l iminated by A N P . D u r i n g the fo l lowing 
reperfusion period, the excretion o f thiols and G S H by 
ANP-exposed livers was simi lar to that of untreated l i v -
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Figure 2. Release of LDH into the perfusate during reperfusion of 
livers after 60 minutes of ischemia in the presence or absence of 
ANP. ANP, 20 nmol/L (•), or ANP, 200 nmol/L (A), were infused for 
20 minutes until perfusion was stopped and were infused again during 
the reperfusion period of 60 minutes (mean ± SD; η = 4). *P< 0.05 
compared with untreated livers ( · ) (n = 5). 
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Figure 3. The effect of ANP on bile flow after 60 minutes of ischemia. 
ANP, 20 nmol/L (•), or ANP, 200 nmol/L (A), were infused before 
and after ischemia as described in Figure 2 (mean ± SD; η = 4). 
*P <0.05 compared with untreated livers ( · ) (n = 5). 
A N P administrat ion. After 60 minutes o f reperfusion, 
lactate release was higher in ANP-treated livers, whereas 
the lactate-pyruvate ratio was unaffected (Table 1). 
Postischemic bile flow reached 0.68 ± 0.18 μΙ· 
m i n _ 1 - g l i v e r - 1 under control conditions and 0.93 — 
0.04 in the presence of 200 nmol/L A N P (Figure 3). 
This significant improvement o f postischemic bile flow 
was paralleled by an augmented bi l iary release of total 
g lutathione (GSH plus GSSG) and GSSG, which recov­
ered to 5 0 % ± 9 % vs. 2 8 % ± 15% and 7 8 % ± 15% 
vs. 4 8 % ± 2 3 % of preischemic efflux rates (Figure 4). 
Thus, the postischemic recovery o f bi le flow and bi l iary 
g lutathione excretion were found to be similar to the 
values obtained i n continuously perfused livers after 90 
minutes. Aga in , 20 nmol/L A N P showed no significant 
effects on postischemic bile flow and bi l iary g lutathione 
release (Figures 3 and 4). 
D u r i n g reperfusion, portal pressure increased mark­
edly (Figure 5), reflecting an impaired hepatic microcir­
culat ion that may tr igger postischemic cell damage and 
liver dysfunction. The t ime course o f porta l pressure dur ­
ing the reperfusion period was unaffected by administra­
t ion o f A N P (Figure 5), suggesting that the vasorelaxant 
nature of A N P may not be responsible for the observed 
protective effects. 
Effects of Preischemic or Postischemic 
ANP Administration on Ischemia/ 
Reperfusion Damage 
To investigate the importance o f the temporal 
relationships o f A N P administrat ion and ischemia for 
the protective action o f A N P in more detai l , livers were 
perfused w i t h 200 nmol/L A N P i n the preischemic or 
postischemic perfusion period only. As shown in Figure 
6, L D H release at 60 minutes o f reperfusion was signi f i ­
cantly reduced by preischemic A N P infusion for 20 m i n ­
utes (23 — 5 m U - m i n - 1 - g l i v e r - 1 ) , comparable w i t h 
the t ime course o f L D H release of continuously A N P -
treated livers. I n contrast, L D H release was s l i ght ly , bu t 
not signif icantly decreased (70 ± 42 m U * m i n - 1 - g 
l i v e r - 1 ) when A N P was administered dur ing the reflow 
period only. The postischemic bi le flow was markedly 
improved by A N P pretreatment (0.86 ± 0.16 
| L l L m i n - 1 g l i v e r - 1 ) bu t not by postischemic infusion 
of A N P (0.64 ± 0.23 μ L · m i n " 1 · g l i v e r - 1 ) (Figure 7). 
Thus, A N P pretreatment only, bu t not postischemic 
A N P adminis t rat ion, protects the liver against ischemia/ 
reper fusion- induced damage. 
Postischemic Bile Flow and Biliary 
Excretion of Glutathione 
As shown i n Figures 3 and 4, the improvement 
o f bile flow by preischemic and postischemic A N P treat­
ment was accompanied by a concomitant increase in b i l i ­
ary g lutathione excretion. Similar results were obtained 
by preischemic A N P treatment, but not by postischemic 
administrat ion. The observed changes i n bile flow ap­
peared to be independent o f changes in bile acid excretion 
because a bile acid- free perfusion buffer was used. To 
examine whether postischemic bile flow depends on the 
bi l iary transport o f g lutathione, the data o f a l l experi­
mental groups were pooled to establish the correlation 
between bile flow and bi l iary excretion o f total g l u t a t h i ­
one. Figure 8 illustrates the relation between bile flow 
and the rate o f g lutathione release after 60 minutes of 
continuous perfusion. A linear correlation (r = 0.96; 
Ρ < 0 . 0 0 1 ) between bi le flow and g lutathione excretion 
was found, ind icat ing that g lutathione may be one of 
the osmotic d r i v i ng forces i n bi le acid—independent bi le 
format ion also after hepatic ischemia. 
Thus, preservation o f postischemic bi le flow by A N P 
can be part ia l ly explained as the consequence o f improved 
bi l iary excretion o f g lutathione. The positive j - i n t e r cep t 
i n the p lot (0.54 \XL-min~l -g l i v e r - 1 ) indicates that in 
addi t ion to g lutathione, there are other compounds re­
sponsible for bile ac id- independent bi le secretion. 
Discussion 
Preservation of Postischemic Liver 
Function by ANP 
The a im o f the present study was to test the hy­
pothesis that A N P protects against ischemia/reperfusion 
in jury o f the liver. This was based on observations that 
A N P prevented cell damage after hypoxia and reoxygena-
t i on i n cul tured hepatocytes. 1 6 Furthermore, A N P pro­
tects cul tured hepatocytes against damage induced by 
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Figure 4. Relative increase of biliary GSSG and GSH release after 60 minutes of ischemia in the presence or absence of ANP. Rat livers were 
perfused with 200 nmol/L ANP (•), 20 nmol/L ANP (^), or without ANP (M) (n = 5) as described in Figure 2. (A) Biliary efflux rates of total 
glutathione (GSH plus GSSG) and (β) GSSG (mean ± SD, η = 4) were compared with preischemic values in each group (100%). Biliary efflux 
rates of total glutathione and GSSG were improved by 200 nmol/L ANP but were not significantly different compared with the other groups. 
ox idants 1 6 ' 1 7 that may contribute to hepatic ischemia/ 
reperfusion in jury . 7 
To investigate the influence o f A N P on ischemia/re­
perfusion damage of the liver w i thou t addit ional effects 
of endogenous A N P / ° we chose the model o f the isolated 
perfused rat l iver . 3 1 * 3 " Reperfusion after 60 minutes o f 
warm ischemia at 37°C resulted i n a sustained increase 
of L D H efflux, indicat ing irreversible cell damage. Fur­
thermore, bile flow (as an index o f postischemic liver 
funct ion ) 3 3 recovered to only 5 0 % - 6 0 % of values ob­
tained i n continuously perfused rat livers after the same 
perfusion period. These observations agree w i t h previous 
reports on perfused rat livers subjected to 60 minutes of 
ischemia at 37°C 3 4 and prolonged warm ischemia (120 
minutes) at room temperature. 2 8 Thus, a model o f consid­
erable hepatic ischemia/reperfusion damage was applied 
to study the pharmacological potent ia l o f A N P . Us ing 
this approach, we have shown that A N P protects the 
liver against ischemia/reflow-induced irreversible cell 
damage, y ie ld ing an improved postischemic liver func­
t ion . The results showed that (1) 200 nmol/L A N P i n ­
fused d u r i n g the preischemic and postischemic perfusion 
period markedly reduced L D H release into the effluent 
perfusate on reperfusion, ind icat ing d im inua t i on o f cell 
damage; (2) postischemic recovery o f bi l iary g lutathione 
excretion and bile flow, wh ich reflect postischemic l iver 
func t i on , 3 3 were improved and s imi lar to values obtained 
in the continuously perfused rat l iver after 90 minutes 
o f perfusion; and (3) b i l iary parameters o f continuously 
perfused livers were unaffected by A N P , rendering u n ­
l ike ly an ANP- induced s t imula t i on o f bile flow or trans­
port processes that could m i m i c improved l iver funct ion. 
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Figure 5. Time course of portal pressure after ischemia in the pres­
ence and absence of ANP. ANP (200 nmol/L) was infused during the 
preischemic and postischemic perfusion period. Portal pressure was 
uninfluenced by ANP (•) compared with untreated livers (B) (n = 5; 
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Figure 6. The effect of preischemic and postischemic administration 
of 200 nmol/L ANP on LDH release after 60 minutes of ischemia. 
ANP (200 nmol/L) was infused for 20 minutes until ischemia only (V) 
and during the first 20 minutes after starting reperfusion (•) 
(mean ± SD; η = 4). *P < 0.05 compared with untreated livers ( · ) 
(n = 5). 
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Figure 7. The effect of preischemic and postischemic administration 
of 200 nmol/L ANP on bile flow after 60 minutes of ischemia. ANP 
(200 nmol/L) was infused as described in Figure 6. The recovery 
of bile flow was markedly improved by ANP pretreatment, but not 
significantly different compared with the other groups. · , untreated 
livers; V, preischemic administration of ANP; • , postischemic admin­
istration of ANP (mean ± SD; η = 4). 
Possible Mechanism of ANP Protection 
After start ing reperfusion, portal pressure t ran­
siently increased, then decreased and almost reached pre­
ischemic values after 10—20 minutes, reflecting impa i r ­
ment and consecutive red is tr ibut ion o f perfusate flow 
through the liver. The protective effects o f vasodilating 
agents on liver funct ion after long hypothermic preserva­
t i on support the contention that an impairment o f he­
patic microcirculat ion may tr igger postischemic cell 
damage. 3 5 W e have recently shown that A N P antago­
nizes phenylephrine-induced vasoconstriction i n the per­
fused rat l i ve r . 3 6 Max ima l vasodilating effects were ob­
served at physiological A N P concentrations (40 pmol/ 
L). I n contrast, 200 nmol/L A N P had no effect on the 
t ime course o f postischemic portal pressure. However, 
improvement o f microc irculat ion need not necessarily 
result in changes o f portal pressure, wh i ch may depend 
on the capacity o f collateral shunt pathways. Moreover, 
20 nmol/L A N P , three orders of magnitude higher than 
the physiological A N P concentration w i t h maximal va­
sorelaxant effects, showed no protect ion. W i t h respect to 
the vasodilating potency o f A N P , the used concentrations 
are extremely h i gh . Thus, different influences o f bo th 
A N P concentrations on the hepatic microc irculat ion 
seem unl ike ly . These results suggest that the hepatic 
microcirculat ion is not improved by vasodilating effects 
of A N P or that improvement o f microc irculat ion is not 
responsible for the observed protect ion. Consistent w i t h 
this interpretat ion, infusion o f 200 nmol/L A N P after 
start ing reperfusion d i d not exhib i t any significant effect 
on hepatic functional recovery, whereas A N P administra­
t i on before ischemia improved postischemic l iver func­
t ion . Moreover, cul tured hepatocytes subjected to hyp­
oxia and reoxygenation were protected by preischemic 
A N P addi t ion , but only to a minor extent by postisch­
emic admin i s t ra t i on . 1 6 These findings lend addit ional 
support for a nonhemodynamic mechanism of A N P pro­
tection. 
The beneficial effect o f preischemic A N P treatment 
suggests that ANP- induced protective mechanisms must 
be in i t ia ted before ischemia to operate dur ing ischemia. 
This view is supported by the marked reduction o f L D H , 
t h i o l , and G S H efflux rates dur ing the first m inu t e o f 
reperfusion in the presence o f A N P . These molecules, 
which are not (or only to a minor extent) taken up by 
the liver, accumulate i n the sinusoidal space as a conse­
quence of increased cell leakiness dur ing ischemia. The 
decreased efflux rates d u r i n g the washout period thus 
reflect reduced damage o f cell membranes d u r i n g the 
ischemic period. Consequently, A N P protects against 
ischemic damage o f the l iver. 
L D H efflux o f untreated livers increased rapidly w i t h i n 
30 minutes o f reperfusion, ind icat ing aggravation o f isch­
emic in jurv , which is generally r e f e r r e d r o as r e p e r f u s i o n 
i n j u r y . 5 ' ' 7 ' 3 8 This later increase of L D H efflux was pre­
vented by A N P . These findings suggest that A N P can 
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Figure 8. Relation between bile flow and glutathione excretion into 
bile after ischemia. For each experimental protocol, one data point 
is illustrated, representing bile flow and excretion of total glutathione 
(sum of GSH plus GSSG expressed as GSH equivalents) 90 minutes 
after starting perfusion and 60 minutes after starting reperfusion, 
respectively. Treatment protocols were as follows: continuous perfu­
sion (Ο, η = 6); continuous perfusion plus 200 nmol/L ANP from 40 
to 70 minutes of perfusion time (•, η = 4); 60 minutes of ischemia 
( · , η = 5); 60 minutes of ischemia plus preischemic and postisch­
emic administration of 200 nmol/L ANP (A, η = 4); 60 minutes of 
ischemia plus preischemic administration of 200 nmol/L ANP 
(Δ , η = 4); 60 minutes of ischemia plus postischemic administration 
of 200 nmol/L ANP (•, η = 4); and 60 minutes of ischemia plus 
preischemic and postischemic administration of 20 nmol/L ANP (•, 
η = 4). A linear correlation was found (r2 = 0.96; Ρ < 0.001) de­
scribed by the equation y = 0.183x + 0.540. 
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also protect against hepatic reperfusion in jury . Intracel lu­
lar and vascular oxidant stress and the product ion of 
mediators o f inf lammation by activated Kupffer's cells 
may contribute to early reperfusion d a m a g e . 9 ' 1 0 , 1 1 , 4 Be­
sides these proposed pathomechanisms and their possible 
modulat ion by A N P , i t is the extent o f ischemic cell 
damage that may determine the vu lnerab i l i ty o f hepato-
cytes to reperfusion injury. Then, prevention of hepatic 
reperfusion injury may be the consequence of the reduc­
t i o n of ischemic cell damage by A N P . 
The lower dose o f A N P (20 nmol/L) used in this proto­
col d i d not show any significant effects on hepatic func­
t iona l recovery and cell damage after ischemia. This ob­
servation is quite consistent w i t h experiments in the 
isolate-perfused kidney, which showed preservation o f 
postischemic renal function by 300 nmol/L A N P , 
whereas 30 nmol/L A N P was w i thou t protective effects. 1 3 
The physiological effects of A N P are mediated by A N P 
receptors"> 9 and may explain the concentration depen­
dency of protection. Binding to the A N P - R 1 receptor 
results in the activation of particulate guanylate cyclase, 
wh i ch converts guanosine triphosphate to cGMP, the 
second messenger that mediates most physiological ef­
fects of A N P . 4 0 , 4 1 Studies w i t h cul tured hepatocytes 
showed a concentration-dependent increase o f cGMP that 
was maximal i n the range of 0 . 1 - 1 . 0 μπιοΙ/L A N P . 1 6 
These data and the findings that ANP-mediated protec­
t i o n against hypoxic damage o f cul tured hepatocytes is 
el iminated in the presence of an inh ib i t o r o f guanylate 
cyclase 1 6 suggest a cGMP-mediated mechanism o f cyto-
protect ion. In contrast, the protective effect o f A N P on 
hepatocytes can be blocked by pertussis tox in w i t h o u t 
lower ing elevated cGMP levels, suggesting the involve­
ment of G-proteins i n the protective action o f A N P . 1 7 
Furthermore, A N P binds to A N P - R 2 receptors, the 
physiological funct ion of which is s t i l l poorly under­
s tood/ 9 I t has been suggested that the A N P - R 2 receptor 
is associated w i t h the activation o f phospholipase C and 
increased formation of inositol phosphates 4 2 Moreover, 
i nh i b i t i on o f sodium t ranspor t 1 7 , 4 ? and adenylate-cy-
clase"^ are discussed as ANP-R2 receptor-mediated pro­
cesses; their role in prevention o f ischemic organ damage 
has not been investigated. 
Damage o f cultured hepatocytes by oxidative stress 
and the accompanying increase i n intracel lular C a 2 + were 
simultaneously prevented by A N P , indicat ing that the 
maintenance of intracellular Ca 2 +-homeostasis may con­
tr ibute to the cytoprotective effects o f A N P . 1 6 The i n ­
crease in cytosolic C a 2 + is considered to be one o f the 
principal factors responsible for the in i t i a t i on of cell dam­
age induced by ischemia, anoxia, or oxidative stress i n 
the l i v e r . 2 , 4 5 , 4 6 However, other studies showed no increase 
o f intracellular C a 2 + un t i l the onset o f lethal cell in jury/ 1 7 
suggesting that C a 2 + increase is a consequence o f cell 
damage. Thus, the modulat ion o f other important patho­
physiological processes by A N P , such as adenosine t r i ­
phosphate deplet ion or cellular proteolysis dur ing isch­
emia/ 4 8 , 4 9 should be investigated to clarify the mechanism 
of A N P cytoprotection i n further detai l . 
Postischemic Bile Flow and Biliary 
Glutathione Transport 
Because a bile acid- free perfusion buffer was used, 
the detected bi le flow main ly represents the bile a c i d -
independent bile f o rmat i on , 5 0 wh i ch accounts for about 
hal f o f the total canalicular bi le flow i n the rat. Ischemia/ 
reperfusion in jury impairs preferentially bile a c i d - i nde ­
pendent bi le flow.51 To characterize postischemic bile 
formation in more detai l , we quantif ied the bi l iary excre­
t i on o f actively transported G S H 2 0 , 2 1 and GSSG, 1 8 , 1 9 
which part ial ly contr ibute to the bile ac id- independent 
bile secretion i n rat l i ver . 5 2 The bi l iary release o f total 
g lutathione and GSSG was markedly decreased du r ing 
the reflow period. The carrier-mediated transport of m o l ­
ecules depends on their intracellular concentration. As 
shown previously, the intracellular concentration o f G S H 
and GSSG is not substantially altered after 30 or 120 
minutes o f warm ischemia , 2 8 , 5 3 suggesting that b i l iary 
transport o f G S H and GSSG is impaired after ischemia. 
ANP-treated livers showed an increased recovery o f b i l i ­
ary g lutathione and GSSG efflux dur ing reperfusion. 
W h e n postischemic bi le flow was plot ted against the 
bi l iary excretion o f total g lutathione, a linear correlation 
was obtained s imi lar to studies under nonischemic condi­
t i ons . 5 2 This shows that an increase in g lutathione excre­
t i on is associated w i t h an increase i n postischemic bi le 
format ion. These findings provide strong support for the 
hypothesis that bi l iary transport o f G S H and GSSG is 
one o f the osmotic d r i v ing forces for hepatic bi le forma­
t i on after ischemia as we l l . However, these results cannot 
exclude the possibi l i ty that bi le flow and glutathione 
transport are being affected i n parallel but independently. 
The bi l iary GSSG-GSH ratio, a sensitive index o f an 
intracel lular oxidant stress, 1 8 , 5 4 and the sinusoidal efflux 
of G S H were not increased i n the presence o f A N P . This 
indicates that augmented bi l iary G S H and GSSG release 
is not the consequence o f st imulated intracellular G S H 
synthesis or G S H oxidat ion to GSSG. I t is more l ike ly 
that improved transport o f G S H into bile w i t h subse­
quent autoxidat ion to GSSG or, in addi t ion, preservation 
of both transport processes by A N P explain our results; 
this agrees w i t h the finding that A N P d i d not increase 
the export o f these molecules i n continuously perfused 
livers. The enhanced transport o f g lutathione may explain 
the improvement o f postischemic bile sa l t - independent 
bi le flow. Other molecules addit ional ly contr ibute to 
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postischemic bile flow, as shown by the positive j - i n t e r -
cept in the p lot o f bile flow vs. g lutathione export. 
I n conclusion, continuous preischemic and postisch­
emic administrat ion of 200 nmol/L A N P or preischemic 
A N P infusion alone reduced ischemia/reperfusion dam­
age o f the liver. This was accompanied by improved 
postischemic bile flow and bi l iary excretion o f g l u t a t h i ­
one. Thus, evidence was found that A N P can act as a 
hepatoprotective hormone that preserves postischemic 
l iver funct ion after 60 minutes o f warm ischemia. The 
strong correlation between postischemic bile flow and 
bi l iary g lutathione excretion indicates that transport o f 
g lutathione is an impor tant osmotic d r i v i ng force for 
hepatic bile formation after l iver ischemia. Final ly, these 
results could suggest a therapeutic potent ia l o f A N P in 
liver resection and graft storage for l iver transplantation, 
wh ich requires further investigation using i n vivo 
models. 
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